Page last updated: 2024-08-17

levodopa and Anxiety

levodopa has been researched along with Anxiety in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (14.00)	18.7374
1990's	5 (10.00)	18.2507
2000's	9 (18.00)	29.6817
2010's	25 (50.00)	24.3611
2020's	4 (8.00)	2.80

Authors

Authors	Studies
Brys, I; Dias, CMV; Leal, DAB	1
Carey, G; Defebvre, L; Dujardin, K; Kuchcinski, G; Leentjens, AFG; Lopes, R; Viard, R	1
Abdelhafiz, AH; Rose, J; Roycroft, M	1
Choudhary, M; Khatri, DK; Singh, SB; Sood, A	1
Abreu, D; Antonini, A; Chendo, I; Coelho, M; Costa, N; Fabbri, M; Ferreira, JJ; Godinho, C; Guedes, LC; Rosa, MM; Sousa, C	1
Benazzouz, A; Faggiani, E; Janssen, MLF; Naudet, F; Temel, Y	1
Cao, B; Chen, Y; Hou, Y; Liu, H; Ou, R; Shang, H; Song, W; Wei, Q; Yuan, X; Zhang, L	1
Ganjavi, H; MacDonald, PA; Vo, A	1
Denibaud, AS; Drieu La Rochelle, C; Loiodice, S; Méot, B; Montagne, P; Rion, B; Viel, R; Wing Young, H	1
Azevedo, LF; Castro-Lopes, J; Cavaco, S; Damásio, J; Fernandes, J; Gonçalves, A; Mendes, A; Moreira, I; Vila-Chã, N	1
Baig, F; Barber, TR; Ben-Shlomo, Y; Hu, MT; Kelly, MJ; Klein, JC; Lawton, MA; Lo, C; Ruffmann, C	1
Bloem, BR; de Greef, MH; Dontje, ML; Kamsma, YP; Krijnen, WP; Munneke, M; Speelman, AD; Stolk, RP; van der Schans, CP; van Nimwegen, M	1
Matsui, K; Oguru, M; Oka, N; Okuda, B; Tachibana, H; Toda, K; Yamanishi, T	1
Acar, F; Acar, G; Karadag, F; Ugurlu, TT	1
Evans, AH; Griffiths, RI; Horne, M; Kettlewell, J; Kotschet, K; McGregor, S	1
Chen, CH; Chen, NF; Chen, WF; Feng, CW; Hsiao, CD; Huang, SY; Hung, HC; Wang, HM; Wen, ZH; Yang, SN	1
De Luka, SR; Kostić, VS; Milovanović, B; Pekmezović, T; Svetel, M	1
Amalric, M; Beurrier, C; Chabbert, D; Concetta, L; Jaouen, F; Kerkerian-Le Goff, L; Langa, F; Marie, H; Melon, C; Révy, D; Salin, P; Tafi, E	1
Arolt, V; Deckert, J; Dlugos, A; Domschke, K; Gajewska, A; Gieselmann, A; Herrmann, MJ; Jacob, C; Markulin, F; Mühlberger, A; Nienhaus, K; Notzon, S; Pauli, P; Reif, A; Unterecker, S; Warrings, B; Winter, B; Zwanzger, P	1
Chiu, WH; Depboylu, C; Hermanns, G; Höglinger, GU; Maurer, L; Oertel, WH; Ries, V; Windolph, A	1
Bellante, F; Dethy, S; Zegers de Beyl, D	1
Berendse, HW; Burgers-Bots, IA; Collette, EH; de Goede, CJ; Ghielen, I; Houniet-de Gier, M; Kwakkel, G; Rutten, S; van den Heuvel, OA; van Vliet, B; van Wegen, EE; Vermunt, K	1
Sethi, K	1
Bungener, C; Montel, SR	1
Angoa-Perez, M; Bishop, C; Eskow Jaunarajs, KL; Kuhn, DM	1
Akat, S; Emre, M; Gurvit, H; Hanagasi, HA; Yazici, J	1
Bishop, C; Button, T; Deak, T; Dupre, KB; Eskow Jaunarajs, KL; Ostock, CY	1
Hamann, M; Lange, N; Richter, A; Shashidharan, P	1
Bugalho, P; Cargaleiro, I; da Silva, JA; Neto, B; Serra, M	1
Bishop, C; Eskow Jaunarajs, KL; George, JA	1
Broussolle, E; Castrioto, A; Chabardès, S; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Mertens, P; Pollak, P; Quesada, JL; Schmitt, E; Thobois, SC	1
Chigir', IP; Fedorova, NV	1
Herkes, GK; McKay, D; Meagher, LJ; Needham, M	1
de Noordhout, AM; Santens, P	1
Barbanoj, M; García-Sánchez, C; Gironell, A; Kulisevsky, J; Pagonabarraga, J; Pascual-Sedano, B	1
Erikh, I; Schlesinger, I; Yarnitsky, D	1
Barker, RA; Kuan, WL; Zhao, JW	1
Bernadt, M; Bhattacharya, SK; Clow, A; Glover, V; Murray, R; Sandler, M; Topham, A	1
Carter, JH; Maricle, RA; Nutt, JG	1
Carter, JH; Maricle, RA; Nutt, JG; Valentine, RJ	1
Brown, D; Factor, SA; Molho, ES; Podskalny, GD	1
Avery, W; Belenky, G; Hall, M; McCann, UD; Popp, K; Sing, H; Thomas, M; Thorne, D	1
Yanagisawa, N	1
Fung, VS; Hely, MA; Morris, JG	1
Gerlach, J; Lühdorf, K	1
McFarland, HR	1
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E	1
Dovedova, EL	1
Kamenetskiĭ, VK; Nuller, IuL	1
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA	1

Reviews

7 review(s) available for levodopa and Anxiety

Article	Year
Anxiety: An ignored aspect of Parkinson's disease lacking attention. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131 Topics: Animals; Anti-Anxiety Agents; Antiparkinson Agents; Anxiety; Disease Progression; Humans; Levodopa; Parkinson Disease	2020
Levodopa unresponsive symptoms in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3 Topics: Antiparkinson Agents; Anxiety; Depression; Dyskinesia, Drug-Induced; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Sweating; Xerostomia	2008
Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment. Neuroscience and biobehavioral reviews, 2011, Volume: 35, Issue:3 Topics: Animals; Antiparkinson Agents; Anxiety; Depression; Disease Models, Animal; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease	2011
Parkinson's disease: drug-induced psychiatric states. Advances in neurology, 1995, Volume: 65 Topics: Aged; Anxiety; Bipolar Disorder; Clozapine; Depression; Electroconvulsive Therapy; Humans; Levodopa; Lisuride; Male; Ondansetron; Parkinson Disease; Psychoses, Substance-Induced; Sexual Dysfunctions, Psychological	1995
[Guidelines of drug therapies for Parkinson's disease]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Anxiety; Cholinergic Antagonists; Dopamine Agonists; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Practice Guidelines as Topic; Quality of Life; Urination Disorders	1997
Treatment of Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2000, Volume: 7, Issue:6 Topics: Age Factors; Animals; Antiparkinson Agents; Anxiety; Catechol O-Methyltransferase Inhibitors; Depression; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease	2000
[Psychiatric manifestations induced by dopamine precursors or antagonists]. Annales medico-psychologiques, 1979, Volume: 137, Issue:9 Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride	1979

Trials

8 trial(s) available for levodopa and Anxiety

Article	Year
Multilevel impact of the dopamine system on the emotion-potentiated startle reflex. Psychopharmacology, 2015, Volume: 232, Issue:11 Topics: Adult; Alleles; Anxiety; Arousal; Carbidopa; Catechol O-Methyltransferase; Dopamine; Double-Blind Method; Drug Combinations; Emotions; Female; Genotype; Humans; Levodopa; Male; Polymorphism, Genetic; Reflex, Startle	2015
BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials, 2015, Jun-23, Volume: 16 Topics: Anxiety; Awareness; Clinical Protocols; Humans; Levodopa; Outcome Assessment, Health Care; Parkinson Disease; Physical Therapy Modalities; Sample Size; Single-Blind Method	2015
Psychostimulant effect of levodopa: reversing sensitisation is possible. Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:1 Topics: Anxiety; Basal Ganglia; Deep Brain Stimulation; Depression; Dopamine Agonists; Dyskinesia, Drug-Induced; Euphoria; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Subthalamic Nucleus	2013
Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:1 Topics: Administration, Oral; Affect; Aged; Antiparkinson Agents; Anxiety; Case-Control Studies; Cross-Over Studies; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Pain Measurement; Parkinson Disease; Time Factors	2007
Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology, 1995, Volume: 45, Issue:9 Topics: Affect; Aged; Anxiety; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1995
The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans. Further evidence for the role of catecholamines in arousal and anxiety. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1995, Volume: 13, Issue:1 Topics: Adult; Affect; alpha-Methyltyrosine; Anxiety; Carbidopa; Catecholamines; Enzyme Inhibitors; Humans; Levodopa; Male; Methyltyrosines; Psychiatric Status Rating Scales; Surveys and Questionnaires; Time Factors; Volunteers	1995
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo. Psychopharmacologia, 1975, Oct-14, Volume: 44, Issue:1 Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Basal Ganglia Diseases; Benserazide; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Drug Combinations; Emotions; Humans; Hydrazines; Levodopa; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Behavior	1975
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease. Neurology, 1974, Volume: 24, Issue:10 Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting	1974

Other Studies

35 other study(ies) available for levodopa and Anxiety

Article	Year
Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients. The International journal of neuroscience, 2023, Volume: 133, Issue:12 Topics: Antiparkinson Agents; Anxiety; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Motor Disorders; Parkinson Disease	2023
Anxiety in Parkinson's Disease Is Associated with Changes in Brain Structural Connectivity. Journal of Parkinson's disease, 2023, Volume: 13, Issue:6 Topics: Anxiety; Brain; Gray Matter; Humans; Levodopa; Parkinson Disease	2023
Patient-controlled variable dosing of levodopa for Parkinson's disease. Age and ageing, 2020, 02-27, Volume: 49, Issue:2 Topics: Aged, 80 and over; Anxiety; Drug Administration Schedule; Female; Humans; Levodopa; Parkinson Disease; Self Administration	2020
Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test. Parkinsonism & related disorders, 2017, Volume: 39 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Blood Pressure; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Visual Analog Scale	2017
Serotonergic neurons mediate the anxiolytic effect of l-DOPA: Neuronal correlates in the amygdala. Neurobiology of disease, 2018, Volume: 110 Topics: Animals; Antiparkinson Agents; Anxiety; Basolateral Nuclear Complex; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonergic Neurons	2018
Vascular risk factors and depression in Parkinson's disease. European journal of neurology, 2018, Volume: 25, Issue:4 Topics: Aged; Alcohol Drinking; Antiparkinson Agents; Anxiety; Asian People; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obesity; Overweight; Parkinson Disease; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Vascular Diseases	2018
Levodopa has mood-enhancing effects in healthy elderly adults. International journal of geriatric psychiatry, 2018, Volume: 33, Issue:4 Topics: Affect; Aged; Antiparkinson Agents; Anxiety; Apathy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2018
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease. Behavioural brain research, 2019, 03-15, Volume: 360 Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; Forelimb; Gait Disorders, Neurologic; Interpersonal Relations; Levodopa; Locomotion; Male; Maze Learning; Memory Disorders; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase	2019
Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease. European journal of pain (London, England), 2019, Volume: 23, Issue:8 Topics: Aged; Antiparkinson Agents; Anxiety; Depression; Disabled Persons; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neuralgia; Parkinson Disease; Surveys and Questionnaires	2019
Predictors of motor complications in early Parkinson's disease: A prospective cohort study. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:8 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cohort Studies; Depression; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index	2019
Quantifying daily physical activity and determinants in sedentary patients with Parkinson's disease. Parkinsonism & related disorders, 2013, Volume: 19, Issue:10 Topics: Age Factors; Aged; Antiparkinson Agents; Anxiety; Body Mass Index; Depression; Educational Status; Energy Metabolism; Female; Guidelines as Topic; Humans; Levodopa; Linear Models; Male; Middle Aged; Motor Activity; Netherlands; Parkinson Disease; Physical Fitness; Sedentary Behavior; Self Efficacy; Sex Factors; Socioeconomic Factors	2013
Clinical correlates of anhedonia in patients with Parkinson's disease. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:12 Topics: Aged; Anhedonia; Antiparkinson Agents; Anxiety; Depression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life	2013
Manic episode following deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a case report. Turkish neurosurgery, 2014, Volume: 24, Issue:1 Topics: Antiparkinson Agents; Anxiety; Bipolar Disorder; Citalopram; Deep Brain Stimulation; Electrodes, Implanted; Female; Humans; Levodopa; Male; Medial Forebrain Bundle; Middle Aged; Parkinson Disease; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Subthalamic Nucleus	2014
A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease. PloS one, 2014, Volume: 9, Issue:2 Topics: Aged; Anxiety; Apathy; Compulsive Behavior; Conditioning, Psychological; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesias; Humans; Hypokinesia; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Weights and Measures	2014
Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish, 2014, Volume: 11, Issue:3 Topics: Animals; Antiparkinson Agents; Anxiety; Biomarkers; Blotting, Western; Carbidopa; Disease Models, Animal; Drug Combinations; Levodopa; Minocycline; Motor Activity; Oxidopamine; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Sympatholytics; Vitamin E; Zebrafish; Zebrafish Proteins	2014
When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease? Vojnosanitetski pregled, 2014, Volume: 71, Issue:4 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Anxiety; Autonomic Nervous System; Case-Control Studies; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prevalence; Psychiatric Status Rating Scales; Serbia; Severity of Illness Index; Time Factors	2014
Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:11 Topics: Animals; Antiparkinson Agents; Anxiety; Cholinergic Neurons; Cocaine; Corpus Striatum; Diphtheria Toxin; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Heparin-binding EGF-like Growth Factor; Humans; Interneurons; Levodopa; Mice, Transgenic; Monosaccharide Transport Proteins; Movement; Neural Pathways; Neurotoxins; Promoter Regions, Genetic; Substantia Nigra	2014
Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease. Neuropharmacology, 2015, Volume: 95 Topics: Animals; Antiparkinson Agents; Anxiety; Benzothiazoles; Depression; Hippocampus; Levodopa; Male; Mice, Inbred C57BL; Neurogenesis; Neurons; Olfactory Bulb; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation	2015
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy. Acta neurologica Belgica, 2016, Volume: 116, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors	2016
Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surgical neurology, 2009, Volume: 72, Issue:2 Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Deep Brain Stimulation; Depression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Education as Topic; Psychomotor Performance; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors	2009
Pain is common in Parkinson's disease. Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Depression; Female; Humans; Levodopa; Male; Middle Aged; Pain; Pain Measurement; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales	2011
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat. Behavioural pharmacology, 2010, Volume: 21, Issue:7 Topics: Amygdala; Animals; Anxiety; Behavioral Research; Biogenic Monoamines; Chromatography, High Pressure Liquid; Corpus Striatum; Depression; Dopamine; Dopamine Agents; Hippocampus; Humans; Levodopa; Male; Models, Animal; Motor Activity; Oxidopamine; Parkinson Disease; Prefrontal Cortex; Rats; Rats, Sprague-Dawley	2010
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia. Pharmacology, biochemistry, and behavior, 2011, Volume: 97, Issue:4 Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Carbidopa; Chromans; Disease Models, Animal; Dystonia; Levodopa; Locomotion; Mice; Mice, Transgenic; Quinpirole; Raclopride	2011
Psychiatric symptoms screening in the early stages of Parkinson's disease. Journal of neurology, 2012, Volume: 259, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Levodopa; Male; Mental Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Surveys and Questionnaires	2012
L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease. Neuroscience, 2012, Aug-30, Volume: 218 Topics: Adrenergic Agents; Animals; Anxiety; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Serotonin	2012
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6 Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome	2006
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:8 Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries	2006
Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey. Acta neurologica Belgica, 2006, Volume: 106, Issue:3 Topics: Aged; Antiparkinson Agents; Anxiety; Belgium; Humans; Levodopa; Mood Disorders; Movement Disorders; Parkinson Disease; Surveys and Questionnaires	2006
Paradoxical kinesia at war. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Anxiety; Cues; Depression; Dyskinesias; Fear; Female; Humans; Israel; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Stress, Psychological; Warfare	2007
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. Psychopharmacology, 2008, Volume: 197, Issue:2 Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nervous System Stimulants; Citalopram; Dopamine Agents; Drinking; Dyskinesia, Drug-Induced; Image Processing, Computer-Assisted; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Sympatholytics; Synaptic Transmission	2008
Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol. Biological psychiatry, 1982, Volume: 17, Issue:7 Topics: Adult; Alcoholism; Anxiety; Creatinine; Ethanol; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors	1982
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:3 Topics: Affect; Aged; Anxiety; Arousal; Carbidopa; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1995
Treating parkinsonism in the era of levodopa. American family physician, 1975, Volume: 12, Issue:3 Topics: Amantadine; Antidepressive Agents; Anxiety; Depression; Histamine H1 Antagonists; Humans; Levodopa; Occupational Therapy; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Tranquilizing Agents	1975
[Mechanism of the action of the delta sleep-inducing peptide against a background of L-DOPA administration]. Biulleten' eksperimental'noi biologii i meditsiny, 1989, Volume: 107, Issue:4 Topics: Acetylcholinesterase; Aggression; Animals; Anxiety; Caudate Nucleus; Delta Sleep-Inducing Peptide; Drug Interactions; Enzyme Activation; Levodopa; Monoamine Oxidase; Motor Cortex; Phenethylamines; Rabbits; Serotonin; Substrate Specificity	1989
[Features of affective disorders in patients with vascular parkinsonism]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1987, Volume: 87, Issue:4 Topics: Aged; Anxiety; Cerebrovascular Disorders; Depression; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Mood Disorders; Parasympatholytics; Parkinson Disease, Secondary	1987